References
- Gibson C. M., Cannon C., Daley W., Dodge J. T. J., Alexander B., Marble S., et al. TIMI Frame Count: A Quantitative Method of Assessing Coronary Artery Flow. Circulation 1996; 93: 879–88
- Vijayalakshmi K., Ashton V. J., Wright R. A., Hall J. A., Stewart M. J., Davies A., et al. Corrected TIMI frame count: applicability in modern digital catheter laboratories when different frame acquisition rates are used. Catheter Cardiovasc Interv 2004; 63: 426–32
- The TIMI Study Group. Thrombolysis in Myocardial Infarction (TIMI) trial., N Engl J Med. 312. 932–6
- van't Hof A., Liem A., Suryapranata H., Hoorntjie J., de Boer M., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998; 97: 2302–6
- Hodgson J., Mancini J., Legrand V., Vogel R. Characterisation of changes in coronary blood flow during the first six seconds after intracoronary contrast injection. Invest Radiol 1985; 20: 246–52
- Bassan M., Ganz W., Marcus H., Swan H. The effect of intracoronary injection of contrast medium upon coronary blood flow. Circulation 1974; 51: 442–5
- Abaci A., Oguzhan A., Eryol N., Ergin A. Effect of Potential Confounding Factors on the Thrombolysis in Myocardial Infarction (TIMI) Trial Frame Count and Its Reproducibility. Circulation 1999; 100: 2219–23
- Bland J., Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307–10
- Gibson C., Murphy S. Determinants of coronary blood flow after thrombolytic administration. J Am Coll Cardiol 1999; 34: 1403–12
- Dotani I., Dodge J. T. J., Goel P. Techniques in the angiographic analysis of coronary flow: past, present and future. J Intervent Cardiol 1999; 9: 429–44
- Faile B., Guzzo J., Tate D., Nichols T., Smith S., Dehmer G. Effect of sex, hemodynamics, body size, and other clinical variables on the corrected Thrombolysis In Myocardial Infarction frame count used as an assessment of coronary blood flow. Am Heart J 2000; 140: 308–14
- Abrams J. The role of nitrates in coronary heart disease. Arch Int Med 1995; 155: 357–64
- Brown B., Bolson E., Peterson R., Pierce C., Dodge H. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation 1981; 64: 1089–97
- Herling I. Intravenous nitroglycerin: clinical pharmacology and therapeutic considerations. Am Heart J 1984; 108: 141–9
- Conti R., Feldman R., Pepine C., Hill J., Conti J. Effect of glyceryl trinitrate on coronary and systemic hemodynamics in man. Am J Med 1983; 27: 28–32
- Pfister M., Seiler C., Fleisch M., Gobel H., Luscher T., Meier B. Nitrate induced coronary vasodilatation:differential effects of sublingual application by capsule or spray. Heart 1998; 80: 365–9
- Aarnoudse W., Fearon W. F., Manoharan G., Geven M., van d V., Rutten M., et al. Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation 2004; 110: 2137–42